Triple
T22457957
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Swissmedic |
E555161
|
entity |
| Predicate | predecessor |
P97
|
FINISHED |
| Object |
Intercantonal Office for the Control of Medicines
The Intercantonal Office for the Control of Medicines was a Swiss regulatory body responsible for overseeing the safety and quality of medicinal products before its functions were taken over at the federal level.
|
E1538036
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Intercantonal Office for the Control of Medicines | Statement: [Swissmedic, predecessor, Intercantonal Office for the Control of Medicines]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Intercantonal Office for the Control of Medicines Context triple: [Swissmedic, predecessor, Intercantonal Office for the Control of Medicines]
-
A.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
-
B.
Federal Service for State Registration of Medicines
The Federal Service for State Registration of Medicines is a Russian government agency responsible for evaluating, approving, and overseeing the circulation of pharmaceutical drugs within the country.
-
C.
Italian Medicines Agency
The Italian Medicines Agency is Italy’s national regulatory authority responsible for evaluating, authorizing, and monitoring medicines and pharmaceutical products.
-
D.
National Agency for Food and Drug Administration and Control
The National Agency for Food and Drug Administration and Control is Nigeria’s federal regulatory body responsible for overseeing the safety, quality, and standardization of food, drugs, cosmetics, medical devices, and related products.
-
E.
Centre for Drug Safety
The Centre for Drug Safety is a specialized unit within the Norwegian Institute of Public Health that focuses on monitoring, researching, and improving the safe use of medicines.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Intercantonal Office for the Control of Medicines Triple: [Swissmedic, predecessor, Intercantonal Office for the Control of Medicines]
Generated description
The Intercantonal Office for the Control of Medicines was a Swiss regulatory body responsible for overseeing the safety and quality of medicinal products before its functions were taken over at the federal level.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Intercantonal Office for the Control of Medicines Target entity description: The Intercantonal Office for the Control of Medicines was a Swiss regulatory body responsible for overseeing the safety and quality of medicinal products before its functions were taken over at the federal level.
-
A.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
-
B.
Federal Service for State Registration of Medicines
The Federal Service for State Registration of Medicines is a Russian government agency responsible for evaluating, approving, and overseeing the circulation of pharmaceutical drugs within the country.
-
C.
Italian Medicines Agency
The Italian Medicines Agency is Italy’s national regulatory authority responsible for evaluating, authorizing, and monitoring medicines and pharmaceutical products.
-
D.
National Agency for Food and Drug Administration and Control
The National Agency for Food and Drug Administration and Control is Nigeria’s federal regulatory body responsible for overseeing the safety, quality, and standardization of food, drugs, cosmetics, medical devices, and related products.
-
E.
Centre for Drug Safety
The Centre for Drug Safety is a specialized unit within the Norwegian Institute of Public Health that focuses on monitoring, researching, and improving the safe use of medicines.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e11e51fdec8190adfdf9f8a6362221 |
completed | April 16, 2026, 5:37 p.m. |
| NER | Named-entity recognition | batch_69f15b7d00208190955a70e2c22d25a4 |
completed | April 29, 2026, 1:14 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_6a0b0c7fc40081909f27eb081ac156f1 |
completed | May 18, 2026, 12:56 p.m. |
| NEDg | Description generation | batch_6a0b0ddb116c8190b19f9a01abb737e6 |
completed | May 18, 2026, 1:02 p.m. |
| NED2 | Entity disambiguation (via description) | batch_6a0b0e4402e481909210c5feff3fcddf |
completed | May 18, 2026, 1:04 p.m. |
Created at: April 16, 2026, 8:48 p.m.